Skip to content
Menu

Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $18

Benzinga Newsdesk 15 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $20 to $18.

Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $20 to $18.

Read at benzinga.com